Dr. Hannah van Kolfschooten is a legal scholar working on law, artificial intelligence, and health, in the Centre for Life Sciences Law, University of Basel.
As an academic competence center, the Centre for Life Sciences Law (ZLSR) at the University of Basel is dedicated to the normative implications of the life sciences. In interdisciplinary cooperation and across all legal disciplines, it examines the interactions between technology and law in an empirically informed manner. It conducts research-based teaching and actively communicates its findings to society. In addition, the ZLSR sees itself as a space for reflection and a source of inspiration for political decision-making processes, which it accompanies analytically and critically.
Dr. Hannah van Kolfschooten (Ph.D., LL.M.) is a legal scholar working at the intersection of law, artificial intelligence, and health. She is a researcher in the Centre for Life Sciences Law at the University of Basel, where her work examines how AI is reshaping healthcare regulation, patients’ rights, and public health governance in Europe and globally. Previously, she was a lecturer-researcher at the University of Amsterdam (2019-2025). She completed her Ph.D. on EU regulation of AI in healthcare and has held visiting positions at Harvard Law School, the University of Verona, and Fondation Brocher.
Alongside her academic research, Hannah contributes expertise to international policy-making and practice. She is a member of the World Health Organization's Technical Advisory Group on AI in Health (WHO TAG-AI) and a recognized expert in AI regulation, human rights, and (digital) health law (European AI Fund; Council of Europe; European Data Protection Board). She also works with NGOs, governments, and health-tech companies on the ethical and legal governance of AI, including EU AI Act implementation, Medical Devices Regulation (MDR/IVDR), and responsible digital health innovation. Her advisory work informs and strengthens her academic research, particularly on questions of human rights, health equity, and the practical challenges of deploying AI in health settings.
She is available for academic collaborations, consulting, expert advisory roles (including ethics boards), and invited speaking engagements on AI governance, the EU AI Act, and digital health law and ethics.